ÂÜÀòÂÒÂ×

Sally John is a scientific advisor at BC Platforms. Sally was previously the VP of Genomics and Computational Biology at Biogen Idec from August 2014 to January 2017. Prior to that, they were an Executive Director at Pfizer from January 2007 to August 2014. Before that, they were a Senior Lecturer and Deputy Director at the University of Manchester from February 2002 to January 2007. Her first job was as a Team Leader at AstraZeneca from January 1999 to December 2001.

Sally John completed their Doctor of Philosophy (PhD) in Immunology and Molecular biology at The University of Manchester.